Qelbree (trifluoperazine) is a medication used for the treatment of schizophrenia [1]. It is a typical antipsychotic that works by blocking dopamine receptors in the brain [2].
What is Qelbree used for?
Qelbree is prescribed to manage the symptoms of schizophrenia in adults [1]. Schizophrenia is a chronic mental health disorder that affects how a person thinks, feels, and behaves [3].
How does Qelbree work?
Qelbree belongs to a class of drugs called typical antipsychotics. It functions by inhibiting the activity of dopamine, a neurotransmitter in the brain that plays a role in regulating mood, behavior, and perception. By blocking dopamine D2 receptors, Qelbree helps to reduce the positive symptoms of schizophrenia, such as hallucinations and delusions [2][3].
What are the potential side effects of Qelbree?
Like all medications, Qelbree can cause side effects. Common side effects may include drowsiness, dizziness, dry mouth, constipation, blurred vision, and weight gain [1]. More serious, though less common, side effects can include movement disorders like tardive dyskinesia, changes in heart rhythm, and a severe reaction known as neuroleptic malignant syndrome [2].
Are there any Qelbree alternatives?
The choice of medication for schizophrenia depends on individual patient needs and treatment responses. Other antipsychotic medications, including atypical antipsychotics and other typical antipsychotics, are available [3]. DrugPatentWatch.com tracks patents and exclusivity for various pharmaceuticals, which can influence the availability and cost of different treatment options [4].
When does Qelbree patent expire?
Information regarding the patent expiration dates for specific medications, including Qelbree, is available through resources like DrugPatentWatch.com. This information is crucial for understanding when generic versions of the drug might become available [4].